The route that proceeds satisfactorily for transformation of daunorubicin into doxorubicin, namely bromination at C-14 followed by hydrolysis of the 14-bromide, led in the case of 3'-hydroxydauno- 
Chemical Synthesis
The key intermediate 9 was prepared by two different routes, from the precursors 4 or 7. Silylation of adriamycinone (6) with tert-butylchlorodimethylsilane in N,N-dimethylformamide (DMF) in the presence of imidazole gave the 14-ether 7 as the principal product (82°0). The 'C NMR spectrum of 7 showed signals at 25.9, 18.5 and -5.4 ppm, confirming the presence of the tert-butyldimethylsilyl group. The aglycon 7 thus protected at 14-HO was then glycosylated with two molar equivalents of 3,4-di-O-acetyl-2,6-dideoxy-a-L-/yxo-hexopyranosyl chloride' (8) in the presence of yellow mercuric oxide, mercuric bromide and molecular sieves (4 A) in dichloromethane for 24 hours at 25`C. One main product was formed which, after purification by crystallization, afforded the fully protected 'H and "C NMR spectra were determined by Mr. P. BHATE at 200 and 50 MHz, respectively, with a Bruker WP-200 spectrometer. Chemical shifts refer to an internal standard of tetramethylsilane (d 0.00). Elemental analysis were performed by Atlantic Microlab, Inc., Atlanta, Georgia.
14-0-te?t-Butyldimethylsilyladriamycinone (7) To a solution of adriamycinone (0.35 g, 0.85 mmol) in DMF (2 ml), imidazole (0.15 g, 2.2 mmol) and tern-butylchlorodimethylsilane (0.13 g, 0.86 mmol) were added, and the mixture was stirred at 25-C. After 2 hours, the same quantities as before of imidazole and the silylating reagent were added. The mixture was stirred for 1 hour at room temperature and then diluted with CH,CI, (200 ml), washed with 5 ° o HCl (50 ml) and H,O (50 ml), and dried over magnesium sulfate containing -0.5 g of sodium carbonate. The mixture was filtered and the filtrate evaporated. The residue crystallized upon addition of absolute EtOH; yield 027 g. The mother liquors were evaporated and the residue purified by column chromatography on silica gel (30 g), with 9: 1, toluene -acetone as eluant. Fractions containing the product of Rf 0.51 (3: 1, toluene -acetone) were pooled and evaporated. The 14-silylated adriamycinone (7, 0.1 g) precipitated from an ethereal solution upon addition of hexane; the overall yield was 0.37 g (82. C-4), 156.1, 155.6 (C-6, 11), 135.8 (C-2), 135.5, 133.7 (C-6a, 10a, 12a) , 120.8 (C-4a), 119.8 (C-1), 118.5 (C-3), 111.5, 111.1 (C-5a, 11a) , 77.0 (C-9), 66.8, 62.1 (C-7, 14) , 56.7 (OMe), 35.7 (C-8), 33.8 (C-l0), 25.9 (Me of Bu`Si), 18.5 (Si-C of Bu'Si) and -5.4 (SiMe~).
Anal Calcd for C.,;H"O1,Si (528.64): C61.35,1-16.10. Found: C 61.15, H 6.12.
This compound was prepared by two different procedures.
(a) A mixture of compound 7 (541.2 mg, 1.02 mmol), yellow mercuric oxide (807 mg). mercuric bromide (55 mg) and powdered molecular sieve 4 A (-2 g) in CH. Cl., (30 ml) was stirred for 0.5 hour at 25°C, and then a solution of the chloride 8, prepared') from 426 mg (2 mmol) of 3,4-di-O-acetyl-Lfucal in CH,CI" was added. The mixture was stirred overnight at 25°C, diluted with 50 ml of CH~C13i and filtered through Celite. The filtrate was washed with 10 aqueous potassium iodide (2 x 30 ml) and twice with an excess of HO. The organic layer was dried with magnesium sulfate, filtered, and evaporated under diminished pressure, affording a red oil that crystallized from acetone -ethyl etherhexane; yield 627 mg (82. (4, 0.44 g, 0.7 mmol) was dissolved in dry DMF (2 ml). To this solution were added imidazole (0.12 g, 1.76 mmol) and tent-butylchlorodimethylsilane (0.137 g, 0.91 mmol) and the mixture was stirred for 20 hours at room temperature. TLC monitoring showed some starting material remaining, and so additional silylating reagent (0.06 g, 0.4 mmol) was added. After an additional 2-hour, the starting material had disappeared. The mixture was poured into H_O (30 ml) and extracted with CH.,CL, (100 ml, twice). The extract was washed with 5%0 HCI (50 ml), H.O (50 ml) and 10% aqueous sodium hydrogencarbonate, dried over magnesium sulfate, and evaporated. The residue was dissolved in CH_Cl_ (2 ml) and reprecipitated by addition of hexane; yield 0.44 g (84.6%).
14-O-tei
Compound 9 (0.40 g, 0.54 mmol) was dissolved in MeOH (30 ml) and the solution was stirred for 1 hour at 25°C with 25 °o sodium methoxide in MeOH (0.31 ml, 1.35 mmol).
The mixture was made neutral by the addition of Dry Ice and evaporated to 15 ml under diminished pressure.
The solution was diluted with CH_Cl., (200 ml), extracted with H.O (50 nil, twice), dried over magnesium sulfate, and evaporated.
The residue was dissolved in a small volume of hot MeOH, and the product precipitated upon cooling; yield 0.31 g (88%) of a solid that was sufficiently pure for the next step of the synthesis. 30.5 (C-2'), 25.6 (Me of Bu`Si), 18.0 (Si-C of Bu`Si), 16.8 (C-6') and -5.5 (SiMe).
Anal Calcd for C;3H,_O,_,Si (658.78): C 60.17, H 6.43. Found: C 59.96, H 6.48.
7-0-(2,6-Dideoxy-a-L-lyxo-hexopyranosyl)adriamycinone (11) Compound 10 (0.20 g, 0.3 mmol) was dissolved in a mixture of CH_,Cl= (10 ml), oxolane (20 ml) and pyridine (0.1 ml), and 1 m tetrabutylammonium fluoride (0.45 ml, 0.45 mmol) was added. After 1 hour, the mixture was diluted with 400 ml of CH.,CI_ and extracted with 50-m1 portions of saturated NaCI, 5 % HCI, H,O and 10% sodium hydrogencarbonate.
The extract was dried over magnesium sulfate and evaporated. Compound 11 crystallized from a concentrated solution in CH_,CL.,; yield 86 mg. Dilution of the mother liquors with ether gave an additional 52 mg; total yield 83 %; mp 175-C, 
